Trial intelligence / Profile preview

Oral NAC in Stable Chronic Bronchitis

NCT00205647Phase 2Completed

Sponsor
Wake Forest University
Start
Jan 1997
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of acetylcysteine in chronic bronchitis (CB), sponsored by Wake Forest University. Started Jan 1997; status: completed.

02

Drugs

acetylcysteine
03

Conditions

chronic bronchitis (CB)

Beyond the preview

Go deeper on NCT00205647.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00205647.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call